DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Chen W, Hill H, Christie A. et al.
Targeting renal cell carcinoma with a HIF-2 antagonist.
Nature 2016;
539: 112-117
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.